The male mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 of Algeria is still 14.9%, with no variation since 2018.
Male mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Algeria
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Algeria
Male CVD, cancer, diabetes or CRD
More indicators for Algeria
Out-of-pocket expenditure PPP per capita
intl dollar259
-intl dollar5
(2021)
Newborns protected against tetanus
97%
-1%
(2022)
Female wasting in children
2.4%
-1.4%
(2019)
Birth registration
99.6%
0%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
44.9%
-3%
(2019)
Algeria Male CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Male CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 14.9% | 0% |
| 2018 | 14.9% | -0.3% |
| 2017 | 15.2% | 0% |
| 2016 | 15.2% | 0% |
| 2015 | 15.2% | 0% |
| 2014 | 15.2% | -0.2% |
| 2013 | 15.4% | -0.4% |
| 2012 | 15.8% | -0.2% |
| 2011 | 16% | -0.2% |
| 2010 | 16.2% | -0.4% |
| 2009 | 16.6% | -0.3% |
| 2008 | 16.9% | -0.3% |
| 2007 | 17.2% | -0.3% |
| 2006 | 17.5% | -0.3% |
| 2005 | 17.8% | -0.3% |
| 2004 | 18.1% | -0.3% |
| 2003 | 18.4% | +0.1% |
| 2002 | 18.3% | -0.3% |
| 2001 | 18.6% | -0.3% |
| 2000 | 18.9% |